Equity Research Report: Standard Engineering Technology Ltd.
(Formerly: Standard Glass Lining Technology Ltd.)
Date: February 7, 2026 (Based on Latest Q3 FY26 Results / Dec 2025)
Market Price (CMP): ₹123.00 (Approx)
Market Cap: ~₹2,460 Cr (Small Cap)
BSE Code: 544333 | NSE Symbol: SETL
1️⃣ Business Model & Work
“From Glass Lining to Total Engineering Solutions”
- Core Business: Company pehle sirf Glass Lined Equipment (Reactors, Storage Tanks) banati thi jo Pharma aur Chemical companies use karti hain (corrosion se bachne ke liye).
- Transformation: Recently company ne apna naam badal kar “Standard Engineering Technology” kiya hai aur business model expand kiya hai:
- Turnkey Solutions: Ab ye sirf equipment nahi, balki puri factory set-up (Design to Commissioning) offer karte hain.
- New Acquisitions: Scigenics (India) (Bioprocess systems) aur C2C Engineering ko acquire karke automation, HVAC, aur civil engineering capabilities add ki hain.
- Revenue Mix:
- Glass Lined Equipment: ~60-70% (Core Cash Cow).
- Turnkey Projects & Trading: ~30% (High Growth Segment).
- Key Clients: Major Pharma & Agrochemical companies (API manufacturers).
2️⃣ Industry & Sector Analysis
Sector: Capital Goods / Engineering (Pharma & Chemical Ancillary)
- Current Status: Sector “Capex Revival” mode me hai. Pharma aur Chemical companies “China Plus One” strategy ke tehat India me manufacturing badha rahi hain, jisse equipment ki demand high hai.
- Cyclical or Secular?: Cyclical with Secular tailwinds. Capex cycles (factory banana) cyclical hoti hain, lekin Pharma demand secular hai.
- Major Competitors:
- GMM Pfaudler: Market Leader (Global giant).
- HLE Glascoat: Strong competitor in filtration & drying.
- De Dietrich Process Systems: Global player.
3️⃣ Latest Financial Performance (Primary Data: Screener/Exchange)
Analysis based on Latest Reported Results (Q3 FY26 – Dec 2025)
| Metric | FY 2023 | FY 2024 | FY 2025 | 9M FY26 (Apr-Dec) | TTM (Trailing 12M) |
| Revenue (₹ Cr) | 210 | 209 | 196 | 562 | 700+ (Est) |
| Op. Profit (EBITDA) | 32 | 37 | 30 | 102 | 130+ (Est) |
| OPM % | 15% | 17% | 15% | 18.2% | 17-18% |
| Net Profit (PAT) | 20 | 26 | 29 | 62 | 78-80 |
| EPS (₹) | 12.75 | 14.52 | 1.44* | 3.64 | ~3.8-4.0 |
| ROE % | 12% | 16% | 15% | — | 15-17% |
Note: EPS variation due to corporate action (Split/Bonus) or equity expansion in FY25. Latest Face Value check recommended.
Latest Quarter (Q3 FY26 – Dec 2025) Highlights:
- Sales: ₹196 Cr (Vs ₹143 Cr last year) → ~37% Growth (YoY).
- EBITDA: ₹34 Cr (Vs ₹29 Cr last year) → ~17% Growth.
- Net Profit: ₹20 Cr (Vs ₹16 Cr last year) → ~25% Growth.
- Observation: Revenue growth bohot sharp hai (due to acquisitions integration), lekin margins thode stable hain (17-18%). New “Integrated Model” kaam kar raha hai.
4️⃣ Management & Shareholding (Latest Available)
- Promoters (60.47%): Kandula Family. Holding stable hai, jo confidence dikhata hai.
- FIIs (2.53%): Chhota participation hai, lekin recent quarters me thoda interest dikhaya hai.
- DIIs (0.76%): Participation abhi negligible hai. Mostly retail aur HNI driven stock hai.
- Management Move: Name change aur Scigenics acquisition management ki “Scale-up” ambition ko dikhata hai. Wo GMM Pfaudler ke dominance ko challenge karna chahte hain comprehensive solution dekar.
5️⃣ Valuation (Latest Market Data)
Valuation: Reasonable compared to Peers
- Current PE Ratio: ~32.6x (Based on TTM earnings).
- Industry PE: Engineering stocks aksar 40-60x PE par trade karte hain (e.g., GMM Pfaudler, HLE Glascoat).
- Price to Book (PB): ~3.2x.
- Peer Comparison:
- GMM Pfaudler: Typically trades at 35-45x PE.
- HLE Glascoat: Often trades at 40x+ PE.
- Verdict: Standard Engineering apne peers se thoda sasta (discounted) mil raha hai, kyunki yeh size me chhota hai aur abhi transformation phase me hai.
6️⃣ Future Growth Triggers (3–5 Years)
- “Concept-to-Commissioning”: Nayi strategy (design se lekar machine lagane tak sab kuch khud karna) client ke liye attractive hai. Isse “Share of Wallet” badhega.
- Export Market: Company global expansion par focus kar rahi hai (Singapre, Thailand via acquisitions).
- Biotech Focus: Scigenics acquisition se company fast-growing Biopharma sector me enter kar gayi hai (Fermenters/Bioreactors), jahan margins traditional pharma equipment se better hain.
7️⃣ Present Situation (Current Outlook)
- Stock Phase: Bullish / Growth Phase. Q3 results strong aaye hain aur market ne “Transformation Story” ko accept kiya hai.
- Recent News: Name change (Standard Glass Lining → Standard Engineering) successfully complete hua hai. Order book strong batayi ja rahi hai (Heat Exchangers demand high).
- Outlook:
- Short Term: Positive momentum due to Q3 numbers. Resistance around ₹135-140.
- Long Term: Agar integration successful raha, to yeh stock Mid-cap banne ki raah par hai.
8️⃣ Risk & Red Flags
- Integration Risk: Do nayi companies (Scigenics & C2C) ko integrate karna mushkil ho sakta hai. Agar culture mismatch hua to execution kharab ho sakta hai.
- Raw Material Volatility: Steel aur Nickel ke prices badhne se margins par pressure aa sakta hai.
- Competition: GMM Pfaudler ek global giant hai; usse compete karna price war shuru kar sakta hai.
9️⃣ Final Verdict
- Summary: Standard Engineering Technology ek “Evolving Small Cap” hai. Yeh ab sirf equipment seller nahi, balki solution provider ban gayi hai. Financials (37% growth) transformation ko validate kar rahe hain.
- For Conservative Investors: Wait & Watch. Company abhi transition phase me hai. Small cap volatility high ho sakti hai.
- For Aggressive Investors: Buy on Dips. Valuation (32x PE) peers ke muqable attractive hai. Agar Biopharma segment grow karta hai, to re-rating ho sakti hai.
- Approx Target Range: ₹150 – ₹160 (12 Months) based on 25% earnings growth expectation.
Risk-Reward: Moderate Risk | High Reward potential (due to low base)
Disclaimer: Ye article sirf educational purpose ke liye hai. Kisi bhi nivesh se pehle apne Financial Advisor se salah zarur lein.